5-132559366-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PP3_Moderate
The ENST00000416135(RAD50):c.-86A>T variant causes a 5 prime UTR premature start codon gain change. The variant allele was found at a frequency of 0.00000481 in 1,455,488 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
ENST00000416135 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENSG00000283782 | ENST00000640655 | c.-86A>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 3 of 26 | 5 | ENSP00000491596.2 | ||||
RAD50 | ENST00000378823.8 | c.212A>T | p.Lys71Met | missense_variant, splice_region_variant | Exon 2 of 25 | 1 | NM_005732.4 | ENSP00000368100.4 | ||
ENSG00000283782 | ENST00000640655.2 | c.-86A>T | splice_region_variant | Exon 3 of 26 | 5 | ENSP00000491596.2 | ||||
ENSG00000283782 | ENST00000640655 | c.-86A>T | 5_prime_UTR_variant | Exon 3 of 26 | 5 | ENSP00000491596.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000481 AC: 7AN: 1455488Hom.: 0 Cov.: 30 AF XY: 0.00000553 AC XY: 4AN XY: 723816
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:2
This variant is not present in population databases (ExAC no frequency). This sequence change replaces lysine with methionine at codon 71 of the RAD50 protein (p.Lys71Met). The lysine residue is highly conserved and there is a moderate physicochemical difference between lysine and methionine. This variant has not been reported in the literature in individuals with RAD50-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
The p.K71M variant (also known as c.212A>T), located in coding exon 2 of the RAD50 gene, results from an A to T substitution at nucleotide position 212. The lysine at codon 71 is replaced by methionine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at